Thrombolysis safety and effectiveness in acute ischemic stroke patients with pre-morbid disability
ConclusionPatients with mRS 2 and 3 may benefit from rt-PA with a moderate risk of sICH and mortality.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Dementia | Disability | Hemorrhagic Stroke | Infectious Diseases | Ischemic Stroke | MRSA | Neurology | Neuroscience | Stroke | Study | Superbugs